Therapy News and Research

RSS

Trigeminal Nerve Stimulation: an interview with Dr Leon Ekchian, President and CEO of NeuroSigma

Trigeminal Nerve Stimulation (TNS) is a novel medical treatment in which mild electrical signals stimulate branches of the trigeminal nerve in order to change the activity of targeted brain regions. The trigeminal nerve is the largest cranial nerve, and provides sensation to the face and head. Because it is a large sensory nerve, the trigeminal offers a high-bandwidth pathway for electrical signals to enter the brain. The brain areas targeted by TNS are known to play key roles in seizures, mood, and attention.

14 Sep 2012

Scientists successfully reverse neuronal changes in autism

People with autism suffer from a pervasive developmental disorder of the brain that becomes evident in early childhood. Peter Scheiffele and Kaspar Vogt, Professors at the Biozentrum of the University of Basel, have identified a specific dysfunction in neuronal circuits that is caused by autism.

14 Sep 2012

Rusk to host community events in recognition of National Rehabilitation Awareness Week

Rusk Rehabilitation at NYU Langone Medical Center (Rusk) will host a series of community events in recognition of National Rehabilitation Awareness Week, September 16-22.

14 Sep 2012

Insufficient evidence to support effectiveness of black cohosh for menopausal symptoms

Although many women coping with hot flashes and other distressing symptoms of menopause have turned to black cohosh supplements as a treatment alternative, a new review by The Cochrane Library finds no evidence that the herb is effective.

14 Sep 2012

Researchers regenerate axons at spinal cord injury site

In a study at the University of California, San Diego and VA San Diego Healthcare, researchers were able to regenerate "an astonishing degree" of axonal growth at the site of severe spinal cord injury in rats.

14 Sep 2012

IU chemists develop fully synthetic artemisinin to help reduce cost of live-saving drugs

In 2010 malaria caused an estimated 665,000 deaths, mostly among African children. Now, chemists at Indiana University have developed a new synthesis for the world's most useful antimalarial drug, artemisinin, giving hope that fully synthetic artemisinin might help reduce the cost of the live-saving drug in the future.

14 Sep 2012

Longer looks: The smells to treat PTSD; Nudging healthy choices; When a disabled daughter was shunned

On an Orlando college campus, veterans and active duty soldiers suffering from post-traumatic stress disorder inhale the unmistakable smell of burning tires, rotting garbage and Middle Eastern spices as part of a virtual reality treatment for the psychological wounds of war. Participants sit in a chair wearing a head-mounted display and video goggles connected to a computer system and a scent machine that puffs out the odors, recreating their memories of war.

14 Sep 2012

Researchers clone T-cell receptor that binds to antigens associated with prostate and breast cancer

Researchers at Uppsala University have cloned a T-cell receptor that binds to an antigen associated with prostate cancer and breast cancer. T cells that have been genetically equipped with this T-cell receptor have the ability to specifically kill prostate and breast cancer cells.

14 Sep 2012

University of Central Florida professor receives NIH’s New Innovator award

The National Institutes of Health today awarded University of Central Florida Professor Ming Su its coveted New Innovator award, which comes with a $2 million grant.

14 Sep 2012

FDA clears Tangent Medical’s NovaCath Secure IV Catheter System

Tangent Medical, an innovator in IV therapy products, today announced it has received FDA 510(k) clearance for the NovaCath Secure IV Catheter System, a product designed to set new standards in peripheral IV catheter design, functionality and performance.

14 Sep 2012

Montelukast possible surgery alternative for obstructive sleep apnea

Leukotriene modifiers may provide a noninvasive treatment option for children with nonsevere obstructive sleep apnea, say researchers.

13 Sep 2012

Platinum tissue concentrations predict NSCLC treatment response

Reduced tissue platinum accumulation might explain why some patients with non-small-cell lung cancer fail to respond to platinum-based chemotherapy, research shows.

13 Sep 2012

Crizotinib may be effective treatment option for NSCLC subtype

Phase I trial results show that the chemotherapy drug crizotinib may be fast-acting and produce long-lasting treatment responses in patients with anaplastic lymphoma receptor tyrosine kinase-positive non-small-cell lung cancer.

13 Sep 2012

FDG–PET/CT improves staging and modifies radiotherapy management

The addition of FDG–positron emission tomography/computed tomography revised radiotherapy decision-making and enhanced tumor staging capabilities in patients with non-small-cell lung cancer, research shows.

13 Sep 2012

Researchers hold new implications for pathogenesis of myotonic dystrophy

An important breakthrough could help in the fight against myotonic dystrophy. The discovery, recently published in the prestigious scientific journal Cell, results from an international collaboration between researchers at the IRCM, the Massachusetts Institute of Technology (MIT), the University of Southern California and Illumina.

13 Sep 2012

Four new studies on the treatment of early breast cancer

Four new studies on the treatment of early breast cancer, spanning from diagnosis through surgery, were released today in advance of the 2012 Breast Cancer Symposium.

13 Sep 2012

Changes in Troponin I protein can lead to cardiac muscle malfunction and precipitate heart failure

A new Johns Hopkins study has unraveled the changes in a key cardiac protein that can lead to heart muscle malfunction and precipitate heart failure.

13 Sep 2012

ACO 'predecessor' saved Medicare money, according to JAMA study

The study, found that the Medicare Physician Group Practice Demonstration resulted in health care savings.

13 Sep 2012

Biodel initiates BIOD-123 Phase 2 trial in Type 1 diabetes

Biodel Inc. today announced the initiation of a Phase 2 clinical trial of its proprietary recombinant insulin (RHI)-based ultra-rapid-acting mealtime insulin candidate, BIOD-123.

13 Sep 2012

Sanford-Burnham professor to develop personalized models of inherited heart conditions

The California Institute for Regenerative Medicine (CIRM) has awarded a $1.58 million grant to Huei-Sheng Vincent Chen, Ph.D., associate professor at Sanford-Burnham Medical Research Institute (Sanford-Burnham). Chen's proposal was one of 28 new projects funded as part of CIRM's Basic Biology IV awards program, which supports basic research aimed at increasing our understanding of stem cells and how to work with them.

13 Sep 2012

Therapy News and Research

Trigeminal Nerve Stimulation: an interview with Dr Leon Ekchian, President and CEO of NeuroSigma

Scientists successfully reverse neuronal changes in autism

Rusk to host community events in recognition of National Rehabilitation Awareness Week

Insufficient evidence to support effectiveness of black cohosh for menopausal symptoms

Researchers regenerate axons at spinal cord injury site

IU chemists develop fully synthetic artemisinin to help reduce cost of live-saving drugs

Longer looks: The smells to treat PTSD; Nudging healthy choices; When a disabled daughter was shunned

Researchers clone T-cell receptor that binds to antigens associated with prostate and breast cancer

University of Central Florida professor receives NIH’s New Innovator award

FDA clears Tangent Medical’s NovaCath Secure IV Catheter System

Montelukast possible surgery alternative for obstructive sleep apnea

Platinum tissue concentrations predict NSCLC treatment response

Crizotinib may be effective treatment option for NSCLC subtype

FDG–PET/CT improves staging and modifies radiotherapy management

Researchers hold new implications for pathogenesis of myotonic dystrophy

Four new studies on the treatment of early breast cancer

Changes in Troponin I protein can lead to cardiac muscle malfunction and precipitate heart failure

ACO 'predecessor' saved Medicare money, according to JAMA study

Biodel initiates BIOD-123 Phase 2 trial in Type 1 diabetes

Sanford-Burnham professor to develop personalized models of inherited heart conditions

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Advancing Intracellular Delivery with LumiPore®

Latest News